Wow. That’s it? Eighteen years in the stem cell trenches, millions in R&D, a big-time stem cell clinical trial in the works and sky-high expectations from patients and investors, and the plug is pulled? Just like that?

Can’t say it’s a complete surprise, having watched the Geron burn rate over the past few years. Last year, losses exceeded $110 million. So far in 2011, about $60 million. Totally unsustainable. But to just turn away from the whole field? Read More

A three-stage combination approach has been used to create a “detour” around a spinal cord injury lesion in an animal experiment. Read More

The role of nervous system helper cells called astrocytes continues to unfold. These cells, once thought to be inert as a sort of spacer for neurons, are now known to play a crucial role in response to nervous system injury. Read More